BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >
Anthony Wilkinson
Anthony Wilkinson
I am a Registered Foreign Lawyer in the Intellectual Property Group, based in our Hong Kong office. As a registered medical practitioner, pharmacist and lawyer, with extensive experience in the global medical industry, I bring a unique background to advise our clients on a broad range of matters in the life sciences space. Outside of my knowledge of hospital medicine, I have a strong background in the regulation and marketing requirements of medicines and devices. I have worked as a Medical Officer (Prescription Medicine) for a government regulator, as well as the Head of Clinical Review for a major European Notified Body. My work in the medical industry has seen me responsible for a range of areas including: medical affairs, government affairs, corporate compliance, business management, regulatory affairs, technology acquisition, reimbursement and clinical affairs. I have spent the last decade living and working for medical companies in Australia, the USA and Hong Kong. I have handled medical product registrations across all major regulated jurisdictions, and I have a deep understanding of the needs of international life sciences clients. I have a specific interest in medical product regulation and understand the increasingly complex regulatory landscape for these products. I look to advise our clients in a number of life sciences areas including IP issues, regulatory issues, marketing authorisations, as well as clinical trial and R&D agreements.
2
Articles
0
Comments
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
The US/China Trade Agreement: what could it mean for the Pharma Industry?
Following a long period of negotiation, Phase I of the US-China Trade Agreement was published on 15 January...
February 6, 2020
5 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.